Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-127893
Filing Date
2012-03-23
Accepted
2012-03-22 19:41:16
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d320749d10ka.htm 10-K/A 932088
2 CONSENT OF OUM & CO. LLP d320749dex231.htm EX-23.1 1563
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER d320749dex311.htm EX-31.1 8455
4 CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER d320749dex321.htm EX-32.1 3604
5 GRAPHIC g320749g23a92.jpg GRAPHIC 41629
  Complete submission text file 0001193125-12-127893.txt   1004272
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27436 | Film No.: 12710250
SIC: 2836 Biological Products, (No Diagnostic Substances)